Oracle Stock Slides to Edge of 52-Week Low as Shares Test Critical Support at $123.66
By TrendSpider Editor
Oracle Corporation shares are under pressure on Friday, July 17, 2026, trading at $123.705 after falling 0.41% and briefly touching $123.66 during Thursday's session, which also marks the stock's 52-week low. The proximity to that floor is the defining story for ORCL right now, with shares sitting a
Oracle Stock Slides to Edge of 52-Week Low as Shares Test Critical Support at $123.66
Oracle Corporation shares are under pressure on Friday, July 17, 2026, trading at $123.705 after falling 0.41% and briefly touching $123.66 during Thursday's session, which also marks the stock's 52-week low. The proximity to that floor is the defining story for ORCL right now, with shares sitting a fraction of a percent away from their lowest level in a year. That weakness stands in sharp contrast to the stock's 52-week high of $345.72, meaning Oracle has shed more than 64% from its peak and now trades near the very bottom of its annual range.
Key Drivers of the ORCL Stock Move
- Main Catalyst: ORCL is classified as a near 52-week low mover, with Thursday's session low of $123.66 matching the stock's 52-week floor exactly. The current price of $123.705 leaves the stock with almost no cushion above that critical technical level.
- Bull Case: The 52-week low at $123.66 represents a well-defined technical support level that traders and long-term investors may treat as a line in the sand. A hold and bounce from this zone could attract buyers who view the more than 64% drawdown from the $345.72 high as an overextended selloff.
- Bear Case: The fact that yesterday's low of $123.66 precisely matched the 52-week low suggests selling pressure has been consistent and persistent. A daily close below $123.66 would represent a new 52-week low and could trigger additional technical selling or stop-loss activity, accelerating the downward move.
The forward setup for Oracle hinges entirely on whether this multi-month support level can hold. Thursday's session showed a wide intraday range between $123.66 and $131.65, indicating volatility and indecision at this critical juncture. The gap between the day's low and high of nearly $8.00 suggests there is still active two-sided trading occurring, but the failure to sustain any intraday recovery and the continued drift toward the 52-week floor reflects a market that remains skeptical. Investors will be watching closely to see whether the $123.66 level acts as a genuine base or simply becomes the next ceiling after a break lower.
ORCL Seasonality
Mid-July historically falls just after Oracle's fiscal fourth-quarter earnings window, a period that can bring elevated volatility as the market digests full-year results and forward guidance. Weakness in the weeks following a fiscal year-end report, if expectations were unmet, can sometimes extend into late summer before stabilizing.
ORCL Relative Performance
With a 0.41% decline on the day and a position at the very bottom of its 52-week range, Oracle is notably underperforming the broader technology sector. While sector peers have also faced pressure in a higher-rate environment, a drawdown of more than 64% from the 52-week high of $345.72 to the current price of $123.705 suggests Oracle has experienced significantly more selling than most large-cap enterprise software names. Until price stabilizes and begins to reclaim ground, ORCL remains a laggard on a relative basis within its peer group.
More on ORCL
- Oracle Stock Plunges 6.59% to $133.83, Approaching the Bottom of Its 52-Week Range
- Oracle Stock Drops 5.54% in Heavy Selloff, Threatening Key Support Near 52-Week Low
- Oracle Options Traders Eye Long-Dated Downside Protection as ORCL Slips Near 52-Week Lows
- Oracle Options Traders Pile Into Deep Out-of-the-Money $360 Calls as ORCL Rises 1.90% on the Session
- Oracle Stock Surges 5.76% on Tuesday, but Still Sits Deep Below 52-Week Highs
Latest Market News
- Mastercard Holds Near 52-Week High as Shares Trade Just Below Record Territory
- UnitedHealth Group Tops Q3 2026 EPS by 13% But Revenue Slides Year Over Year
- RBC Capital Stands Firm on AbbVie With Buy Rating as Stock Flirts With 52-Week High
- PepsiCo Trades Near 52-Week Low as Stock Hovers Just Above $123.47 Floor
- Philip Morris Stock Hovers Near 52-Week High as Shares Consolidate at $205.62
- Apple Stock Hovers Just Below Its 52-Week High as Bullish Momentum Builds